At Anjarium we are advancing our Hybridosome™ technology to leverage unmatched advantages in the realm of engineering extracellular vesicles (incl. exosomes) to act as smart carriers and to maximize the therapeutic potential of naturally occurring vesicles.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2016
  • Number of employees in Switzerland
    1-9
Key business
Core competencies